The global rapid self-healing gel market size was valued at USD 250 million in 2021 and is projected to reach around USD 500 million in 2030 exhibiting a CAGR of 8.0% in the forecasted period. The rise in trauma and chronic wound conditions, growth in the clinical trials are shown to augment the efficiency of rapid self-healing gel are the foremost aspects that boost the development of the global rapid self-healing gel market. On the other hand, unbalanced raw material costs will hamper market development are projected to hamper the growth of rapid self-healing gel market growth.
The growing incidences trauma and chronic wound cases are expected to drive growth in the global rapid self-healing gel market during the forecast period. According to an article issued in Ecronicon, chronic wounds distress 6% of the global population, with the elderly population being the most affected. Also, an upsurge in the R&D for augmenting the efficacy of rapid self-healing gel is foreseen to increase the market growth during the forecasted period. As per the United States National Library of Medicine, 553 clinical trials including hydrogels have been recognized, with 73 currently underway.
The escalating R&D activities may assist in the expansion of innovative rapid self-healing gels that are proposed to boost the global rapid self-healing gel market through the assessed period. Scientists at the National University of Singapore made an innovation in the self-healing gel domain, as per the Nature Scientific Journal article, by rising a water-resistant hydrogel that heals itself in the face of mechanical stress. The self-healing gel is prepared of fluorine-based polymer and look like jellyfish skin. Old-style self-healing gels lacked water resistance, restraining their use in electrical applications. This fluorine-based self-healing gel disables the restrictions of conservative self-healing gels, permitting it to generate aquatic soft robots and water-resistant mobile screens.
The COVID-19 outbreak has impacted the complete pharmaceutical supply chain, generally owing to the extreme lockdown in some zones. The coronavirus pandemic has compressed the development, manufacturing, and supply of medications as well as the procedures of several firms involved in the global healthcare business. Apart from the production of requirements, the pandemic mandates the closing of industrial facilities and interrupted the product supply chain. Owing to the drop in production and supply of the raw ingredients needed to manufacture self-healing gels across the pandemic, the influence of the coronavirus (COVID-19) pandemic is estimated to hinder the growth of the global market for rapid self-healing gel during the forecasted period.
Crosslinking Insights
Among both, chemical crosslinking held a higher share of the market in the last few years. It includes the use of covalent bonding amongst polymer chains to grow self-healing hydrogel. Changing chemical bonds is that results in the expansion of self-healing properties in hydrogels. Once exterior stress is applied & detached, self-restoring resources relapse to their original shape & mechanical features. The advantages of chemically cross-linked hydrogels, such as improved stability, robustness, and higher tensile, shear, & winding strength than physically cross-linked hydrogels, are the main causes that caused in their maximum market share in the last years.
Application Insights
Here, the drug delivery application is anticipated to acquire a significant market share during the forecasted period. It features to the increasing demand for new drug delivery systems and enormous R&D investments in self-healing gels. Scientists in the US have presented a self-healing hydrogel that can be inoculated using a syringe, carry two drugs at once, and doesn’t include surgical grafting, which permits for more suitable treatment of several circumstances & improved adaptabilities in drug administration. Since self-healing hydrogels can be moulded into detailed shapes, offer treatment over longer durations, and target specific matters with treatment owing to their static nature, it projects a notable share of the drug delivery application in the global rapid self-healing gel market during the forecasted period.
Region Insights
Of all regions globally, North America is expected to continue its domination in the market. It is owing to the extensive presence of well-known public & private educational organizations, which are considerably investing in evolving innovative gels & treatments, along with the expanding prevalence of chronic wounds through the region.
Moreover, the important players functioning in the regional market are signing patent license agreements and introducing new products based on polymers & resins to cater to an extensive range of applications. Furthermore, remarkable advancements in healthcare & pharmaceutical industries and ever-increasing medical expenditure are other noticeable features anticipated to drive the rapid self-healing gel market in North America during the forecast years.
However, Asia-Pacific rapid self-healing gel market is anticipated to record a stable growth rate in the upcoming years. It attributed to the developing demand for modern drug delivery systems in many nations, along with growing investments & mounting demand for specialty products in the healthcare sector.
Key Companies Insights
The market for rapid self-healing gel is moderately competitive. With the rising applications of rapid self-healing gel, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the Rapid self-healing gel market, ultimately boosting the market growth. Some of the key companies working in the global Rapid self-healing gel market include:
• Axelgaard
• Hydromer Inc.
• Alliqua Biomedical
• Contura International
• Cytogel Pharma
• Scapa Healthcare
• R&D Medical Products, Inc.
• Advanced Medical Solutions Group PLC
• Katecho Inc.
• Cardinal Health
• Biogelex
• Conforma
• Ferentis
• ABC Farma Internacional
• Other players
Some of the Recent Developments:
• In October 2021, Scapa Healthcare & Synedgen Inc signed a licensing agreement for two innovative wound care treatments established using Synedgen’s proprietary glycochemistry technology platform. The agreement also offers Scapa Healthcare the right to use the glycopolymer technology in mixture with other wound care technologies.
• In September 2021, Contura International Ltd. introduced a latest injectable treatment for knee osteoarthritis (OA) that attributes Arthrosamid that permits a less invasive, long-acting, & safe managing for knee OA.
Segments
By Crosslinking
• Physical
• Chemical
By Application
• Wound Healing
• Drug Delivery
• Tissue Engineering
• 3D Printing
• Surface Coating
• Soft Robots
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt